Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -26.02%3.78M | 3.07M | 40.68%27.02M | -9.59%3.69M | -81.17%4.18M | -70.26%19.21M | 4.09M | -80.00%4.44M | 5.11M | -73.82%5.57M |
| Cost of revenue | -30.79%2.9M | 2.59M | 37.68%22.09M | -11.86%3.08M | -75.73%3.25M | -68.44%16.05M | 3.49M | -74.61%3.4M | 4.2M | -61.37%4.96M |
| Gross profit | -4.15%878K | 478K | 55.90%4.93M | 3.70%617K | -89.45%928K | -76.99%3.16M | 595K | -88.20%1.04M | 916K | -92.73%614K |
| Operating expense | -69.28%1.88M | 1.8M | 352.71%93.13M | 1,884.71%69.82M | -57.07%2.34M | -88.04%20.57M | 3.52M | -21.97%4.25M | 6.11M | 26.04%6.69M |
| Selling and administrative expenses | -67.22%1.87M | --1.8M | 48.32%27.81M | 141.84%7.11M | -41.83%2.34M | -16.33%18.75M | --2.94M | -11.03%3.57M | --5.72M | 38.58%6.52M |
| -Selling and marketing expense | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -General and administrative expense | -67.22%1.87M | --1.8M | 48.32%27.81M | 141.84%7.11M | -41.77%2.34M | -16.22%18.75M | --2.94M | -10.94%3.57M | --5.72M | 38.79%6.52M |
| Other operating expenses | -99.24%3K | --7K | 3,485.07%65.32M | 10,749.83%62.71M | -99.93%1K | -98.78%1.82M | --578K | -52.73%675K | --394K | -71.17%175K |
| Operating profit | 80.77%-999K | -1.33M | -406.65%-88.2M | -2,267.60%-69.21M | -141.98%-1.41M | 89.00%-17.41M | -2.92M | -195.65%-3.21M | -5.2M | -294.19%-6.08M |
| Net non-operating interest income (expenses) | 81.95%-98K | -47K | 0.98%-1.21M | 43.22%-180K | 62.79%-211K | -25.72%-1.22M | -317K | 47.62%-297K | -543K | 80.18%-65K |
| Non-operating interest income | --40K | ---- | --434K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Non-operating interest expense | -74.95%136K | --47K | 34.53%1.64M | -43.22%180K | -62.79%211K | -18.48%1.22M | --317K | -47.62%297K | --543K | -80.18%65K |
| Total other finance cost | --2K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment income | 18K | |||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 387K | |||||||||
| Less:Impairment of capital assets | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | ---- | ---- | ---354K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Write off | ---- | ---- | ---33K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | -81.77%64K | 101K | 239.23%2.8M | 1,618.47%2.7M | -92.35%117K | -98.35%826K | 157K | -83.73%249K | 351K | -65.15%69K |
| Income before tax | 80.73%-1.04M | -1.27M | -384.16%-86.2M | -2,063.06%-66.69M | -134.80%-1.5M | 83.39%-17.8M | -3.08M | -175.43%-3.26M | -5.39M | -302.47%-6.08M |
| Income tax | 0 | 0 | 0.00%-5.87M | 0 | 0 | -149.64%-5.87M | 0 | -479.50%-5.87M | 0 | 0 |
| Net income | 80.73%-1.04M | -1.27M | -572.97%-80.33M | -2,063.06%-66.69M | -154.20%-1.5M | 89.97%-11.94M | -3.08M | -5.91%2.61M | -5.39M | -579.56%-6.08M |
| Net income continuous operations | 80.73%-1.04M | ---1.27M | -572.97%-80.33M | -2,063.06%-66.69M | -154.20%-1.5M | 89.97%-11.94M | ---3.08M | -5.91%2.61M | ---5.39M | -579.56%-6.08M |
| Noncontrolling interests | 47.02%222K | 14K | 222.95%394K | -89.81%11K | -72.25%247K | 106.27%122K | 108K | -95.28%42K | 151K | 79.26%-179K |
| Net income attributable to the company | 77.27%-1.26M | -1.29M | -569.43%-80.73M | -1,990.19%-66.7M | -192.94%-1.75M | 89.70%-12.06M | -3.19M | 36.33%2.57M | -5.54M | -376.85%-5.9M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 77.27%-1.26M | -1.29M | -569.43%-80.73M | -1,990.19%-66.7M | -192.94%-1.75M | 89.70%-12.06M | -3.19M | 36.33%2.57M | -5.54M | -376.85%-5.9M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 84.93%-0.0011 | -0.0011 | -510.34%-0.0708 | -1,787.10%-0.0585 | -142.86%-0.0015 | 94.36%-0.0116 | -0.0031 | -20.00%0.0028 | -0.0073 | -331.71%-0.0095 |
| Diluted earnings per share | 84.93%-0.0011 | -0.0011 | -510.34%-0.0708 | -1,787.10%-0.0585 | -142.86%-0.0015 | 94.36%-0.0116 | -0.0031 | -60.00%0.0014 | -0.0073 | -331.71%-0.0095 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.